dr. roy s. herbst discusses immunotherapy in squamous and nonsquamous nsclc
Published 8 years ago • 141 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:00
dr. herbst discusses immunotherapy in lung cancer
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:12
dr. roy herbst on the emergence of immunotherapy in cancer
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
1:18
dr. herbst on next-generation agents in nsclc
-
2:29
dr. herbst discusses the state of immunotherapy in lung cancer
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
2:41
dr. roy herbst describes the efficacy of immune checkpoint inhibitors
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:45
dr. herbst discusses challenges with immunotherapy in nsclc
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:03
dr. roy herbst on antibodies used against egfr alongside chemotherapy
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:26
dr. herbst on mpdl3280a for non-small cell lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials